AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
eXoZymes Inc. Common Stock
XNAS · usd
SIC 2836 · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
FIGI BBG01LFVT5J4
4.00▲ 0.10 (2.56%)
As of 2026-10-23
Price / Volume
Valuation
Market Cap
Enterprise Value
Trailing P/E
—
Price / Sales
—
EV / Revenue
—
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
—
Net Debt
Trading Information
Previous Close
3.90
Day's Range
3.85 – 4.44
52-Week Range
3.71 – 18.40
Volume
14.3K
Avg Volume
10.8K
Share Statistics
Shares Outstanding
Employees
32
Exchange
XNAS
Listed
2024-11-13
Share count as of August 13, 2026

eXoZymes Inc. Common Stock (EXOZ) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about eXoZymes Inc. Common Stock (EXOZ)
What is eXoZymes Inc. Common Stock's Market Cap?
eXoZymes Inc. Common Stock's Market Cap is $37.1M, based on as-reported figures from SEC (XBRL) filings.
What is eXoZymes Inc. Common Stock's Enterprise Value?
eXoZymes Inc. Common Stock's Enterprise Value is $31.6M, based on as-reported figures from SEC (XBRL) filings.
What is eXoZymes Inc. Common Stock's EV / EBITDA?
eXoZymes Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is eXoZymes Inc. Common Stock's Revenue (TTM)?
eXoZymes Inc. Common Stock's Revenue (TTM) is $0.00, based on as-reported figures from SEC (XBRL) filings.
What is eXoZymes Inc. Common Stock's Net Income (TTM)?
eXoZymes Inc. Common Stock's Net Income (TTM) is -$10.2M, based on as-reported figures from SEC (XBRL) filings.
What is eXoZymes Inc. Common Stock's EBITDA?
eXoZymes Inc. Common Stock's EBITDA is -$10.3M, based on as-reported figures from SEC (XBRL) filings.
What is eXoZymes Inc. Common Stock's Diluted EPS (TTM)?
eXoZymes Inc. Common Stock's Diluted EPS (TTM) is -1.10, based on as-reported figures from SEC (XBRL) filings.
What is eXoZymes Inc. Common Stock's Net Debt?
eXoZymes Inc. Common Stock's Net Debt is -$5.6M, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · EXOZAs-filed SEC (XBRL) data
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023
Revenue————
General and administrative costs:
Cost of Revenue
Professional Fees
Other Operating Expense
Selling, General and Administrative Expense
Total general and administrative costs
Research and Development Expense
Total operating costs
Net operating loss
% of revenue————
Other income/(expense):
Interest Expense
Offering costs———
Non-Operating Income (Expense)——
Loss before income taxes
Income Tax Expense————
Net loss
% of revenue————
Earnings Per Share (Basic)
Earnings Per Share (Diluted)